Edoardo Faggionato received the bachelor’s degree in biomedical engineering, in 2018, and the master’s degree cum laude in bioengineering, in 2020, from the University of Padova, Padova, Italy. During his master studies, he took part at the Erasmus+ exchange program spending a semester at the Chalmers University of Technology, Göteborg, Sweden. He is currently a second year PhD student with the Department of Information Engineering of the University of Padova. His research focus on the development of nonlinear mixed effects models for the kinetics of substrates and hormones involved in the glycemic control. At the moment, he is a visiting researcher at the University of Cape Town, South Africa, where he collaborates with the pharmacometrics group.

Pierpaolo Falcetta is a first year Ph.D student in the Clinical and Traslational Sciences course at University of Pisa. His research activity is mainly focused on the clinical and prognostic implications of kidney disease in people with diabetes. He is currently studying the role of several inflammatory and profibrotic molecules secreted by tubular epithelial cells of the kidney as a non-invasive biomarkers for ongoing kidney injury and progressive kidney disease. He has also shown keen interest in the study of advanced technologies and alternative markers of glycemic control applied to special populations of patients with diabetes, e.g. those on maintenance hemodialysis.

Eileen R. Faulds, PhD, FNP-BC, RN, CDCES is an assistant professor, tenure track, at The Ohio State University (OSU) College of Nursing. Her National Institutes of Health (NIH) funded research is focused on understanding novel aspects of diabetes and technology management and the experience of individuals with diabetes and their relationship with technology (i.e., insulin pump, continuous glucose monitoring, automated insulin delivery devices). Over her 11-years of experience as an endocrinology nurse practitioner, certified diabetes educator, and certified insulin pump trainer, she has practiced in inpatient and outpatient settings with children and adults with type 1 diabetes (T1D). Dr. Faulds has worked extensively with interdisciplinary teams in the implementation of and use of diabetes technology in the inpatient setting. Her research also involves the use of game based and simulation technologies to craft innovative diabetes self-management solutions for individuals with diabetes. Dr. Faulds work utilizes patient device data to personalize self-management and technology solutions to meet people with diabetes unique needs.